THE DEAL, AT A GLANCE
From the announcementAdjuvia Therapeutics
01Who is involvedBacked by JLO Ventures, with Portfolia Ventures participating, Portfolia Ventures, experienced biopharmaceutical industry leadersFrom the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗02What happenedAdjuvia Therapeutics raised $8M Seed, announced 2026-07-30From the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗03Why it mattersAdjuvia Therapeutics' seed financing supports development of ATI-105 for mitochondrial dysfunction and disease.From the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗Click a part to explore its evidence. Unsupported imagery is withheld rather than guessed.Original record source ↗
Adjuvia Therapeutics · Financing Record
Explore source-linked visual explanations for Adjuvia Therapeutics. Unsupported claims are withheld while source review continues.
Record 9551 · Recorded date: 2026-07-30
Explore company records →